1616852-00-6

Basic information

• Product Name: 2-(1-(1-(3-(2-chloro-5-methoxyphenoxy)-4-methylpentyl)piperidin-4-yl)-3-hydroxy-2-oxoindolin-3-yl)-N,N-dimethylacetamide
• Synonyms: 2-(1-(1-(3-(2-chloro-5-methoxyphenoxy)-4-methylpentyl)piperidin-4-yl)-3-hydroxy-2-oxoindolin-3-yl)-N,N-dimethylacetamide
• CAS NO: 1616852-00-6
• Molecular Weight: 558.118
• Mol File: 1616852-00-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(1-(1-(3-(2-chloro-5-methoxyphenoxy)-4-methylpentyl)piperidin-4-yl)-3-hydroxy-2-oxoindolin-3-yl)-N,N-dimethylacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(1-(1-(3-(2-chloro-5-methoxyphenoxy)-4-methylpentyl)piperidin-4-yl)-3-hydroxy-2-oxoindolin-3-yl)-N,N-dimethylacetamide(1616852-00-6)
• EPA Substance Registry System: 2-(1-(1-(3-(2-chloro-5-methoxyphenoxy)-4-methylpentyl)piperidin-4-yl)-3-hydroxy-2-oxoindolin-3-yl)-N,N-dimethylacetamide(1616852-00-6)

Safety Data

• Hazardous Substances Data: 1616852-00-6(Hazardous Substances Data)

Upstream product

• 400797-94-6 tert-butyl 4-(2-oxo-2,3-dihydro-1H-indol-1-yl)piperidine-1-carboxylate 
• 35613-44-6 2-aminophenylacetic acid methyl ester 
• 3740-52-1 2-(2-nitrophenyl)acetic acid 
• 30095-98-8 methyl (2-nitrophenyl)acetate 
• 1616854-30-8 2-(1-(1-(3-(2-chloro-5-methoxyphenoxy)-4-methylpentyl)piperidin-4-yl)-2-oxoindolin-3-yl)-N,N-dimethylacetamide 
• 1616855-27-6 tert-butyl 4-(3-(2-(dimethylamino)-2-oxoethyl)-2-oxoindolin-1-yl)piperidine-1-carboxylate 
• 478613-43-3 3-(2-chloro-5-methoxyphenoxy)-4-methylpentyl methanesulfonate 
• 1616855-08-3 3-(2-chloro-5-methoxyphenoxy)-4-methylpentan-1-ol 
• 1616855-06-1 1-hydroxy-4-methylpentan-3-yl methanesulfonate 
• 1616855-04-9 methyl 4-methyl-3-(methylsulfonyloxy)pentanoate 
• 65596-31-8 methyl 3-hydroxy-4-methylpentanoate 
• 42558-54-3 Methyl 4-methyl-3-oxopentanoate 
• 1616855-18-5 tert-butyl 4-(3-(2-methoxy-2-oxoethyl)-2-oxoindolin-1-yl)piperidine-1-carboxylate 
• 18113-04-7 2-chloro-5-methoxy-phenol 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF

Provided herein are heterocyclyl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.